Disc Medicine, Inc. (IRON)
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Disc Medicine, Inc.
NASDAQ:IRONHealthcare · Biotechnology
-4.26%$76.59
CLOSED · Nov 16Prev close$80.00-4.26%Close$76.590.00%AH close$76.59
AH$76.59+0.00%vs close
Mkt Cap$3.49B
EV-
Float32.73M
O/S45.54M
VOL817K sh
$ Vol$63.41M
RVOL0.49×
Inst Own97.4%
SI21.0%
Net Cash/Sh-
Dilution
MCap$3.49BFloat32.73MO/S45.54M
Dilution